=====================
Puration, Inc. (PURA)
Alert Price: $0.0698
Price Target: $0.35 (Goldman Small Cap Research)
Float: 537.87M
Website | Recent News
========================
Members,
U.S. stocks tumbled sharply today, extending Tuesday’s declines after a weak batch of economic data sparked concerns over the pace of global and domestic growth.
With all the doom and gloom surrounding Wall St., it's been extremely difficult to find any bright spots.
One sector that did stand out however was Cannabis.
And one company that stood out particularly was Puration, Inc. (PURA).
PURA closed the day out near session highs, while trading on higher than average volume.
This is normally a strong sign of bullish momentum, and from a technical perspective, this appears to be a no brainer,.
However, there is so much more to this company than just strong technicals.
PURA has witnessed growth of 87%, and is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
PURA Will Soon Be Grabbing The Full Attention Of Wall St.
CBD Beverage Industry Survey Update Coming Next Week Followed By Next New Beverage Announcement
Today the Company announced plans to release additional information from its recent CBD beverage industry survey. Earlier today, PURA announced that Goldman Small Cap Research has issued an “Alert” follow-up to a recent Research Analyst Report issued on PURA. The Research Analyst Report was triggered by an earlier CBD Beverage Industry Survey conducted on behalf of a PURA initiative to launch new CBD infused beer, coffee and tea beverages. The trade alert today indicates the definitive survey results and analysis will be coming next week in a further update to be issued by Goldman.
PURA Announces Trade Alert Featuring "Rare Entry" Opportunity With "Triple" Potential
Today PURA announced a research analyst trade alert highlighting a "rare entry" price opportunity for the shares of PURA and the potential for the share price to triple from current levels. Early last week, PURA reached a PPS of $0.09 more than doubling the PPS from a week earlier. On Wednesday last week, September 25th, 2019, Goldman Small Cap Research issued an analyst research report recommending a speculative buy and $0.35 target PPS. Since that time, the PPS has retraced to close yesterday at $0.06. In reaction to the recent trading activity, Goldman today issued a trade alert.
"In recent trading sessions, PURA's stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks."
Two weeks ago, Goldman published the initial results from a CBD Beverage Industry Survey it had conducted on behalf of a PURA initiative to launch new CBD infused beer, coffee and tea beverages. The trade alert today indicates the definitive survey results and analysis will be coming next week.
The Goldman alert today offers commentary on possible explanations for the recent PURA trading activity:
"So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks."
To see the full trade alert issued today, follow the link below:
www.goldmanresearch....c-pura-spec-buy.html
About Puration Inc.
PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
For more information on Puration, visit www.purationinc.com
Company Highlights
87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
Announced new distribution agreement for its EVERx CBD Sports Water in Europe anticipated to generate $4 million in annual revenue.
Sales On Track To Reach $4 Million 2019 Revenue Target
Launched a pre-marketing campaign of its new CBD Infused beer, coffee and tea beverages.
Goldman Small Cap Research Confirms PURA Speculative BUY and $0.35 PPS Target (+400%! Upside From Today's Alert Price)
A first mover in the CBD sports market. Already ahead of CBD giant Aurora Cannabis
Recently announced the launch of its EVERx CBD Sports Water marketing campaign in Europe.
EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales in 2018 and over $1 million in sales in the first six months of 2019 and targeting $4 million in sales by 2019 year end. EVERx is now an official sponsor of Jan Tana's Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide.
EVERx CBD Sports Water is available for purchase on line at www.USMJ.com hosted by PURA's partner North American Cannabis Holdings, Inc. (USMJ).
Bullish Catalysts for PURA
First Shipment of EVERx CBD Sports Water Heads to Europe Next Month
$4 Million 2020 Projection for New Distribution Agreement
PURA New TranquiliTeaCBD Beverage Included in Shipments by Year End
Agreement Supports Analyst Rev Projection and Spec Buy w/$0.35 TGT PPS
Analysts Project $8M in Revenue this Year
Last week the Company announced the European Distribution Agreement for their EVERx CBD Sports Water and other future CBD infused beverages coming soon. The distributor is a supplier to a grocery chain with approximately 4 Billion Euro in annual sales. The agreement is anticipated to generate one million dollars in sales per quarter in 2020 supporting a recent analyst projection for PURA sales reaching $8 million next year (see more on the $8 million 2020 projection below). The first shipment will go out to the new European Distributor next month and Q4 2019 sales will contribute to refining the 2020 $4 million forecast. PURA expects to add its new TranquiliTeaCBD beverage introduced yesterday to the European Distribution shipments before the end of 2020.
In reaction to shareholder questions regarding the new distribution agreement recently announced, PURA confirmed that the anticipated $4 million from the new distribution agreement is separate from and on top of the existing $4 million, 2019 revenue target.
Source: finance.yahoo.com/ne...llion-161115964.html
PURA 2019 $4 Million Revenue Target On Track And Shareholders Are One Big Step Closer To Receiving Stock Dividend
PURA Reports 87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
PURA Posts $122,000 Net Income From Operations
Sales On Track To Reach $4 Million 2019 Revenue Target
NOUV Issues Preferred Stock To PURA For PURA Shareholder Dividend
In August the Company published a management update in conjunction with the recently published 2019 Q2 Financial Report. The company reported over $1 million in revenue for the first six months of 2019. The 2019 revenue for the first six months of 2019 is 87% higher than the revenue reported for the same period in 2018. The company also posted $122,000 in net income from operations for the first six months of 2019.
CEO Brian Shibley Update:
PURA has announced a $4 million revenue target for 2019. The company broke $1 million in sales for the 2018 fiscal year. I believe the Q2 2019 report demonstrates that the company can reach its $4 million revenue target.
I actually believe sales could have been even higher in the first six months of 2019. We had reached production capacity on our EVERx CBD Sports Water and spent considerable time and effort in the first half of the year overcoming our production constraints. Had we not been constrained, I believe we would have realized more sales in the first two quarters. We simply could not make enough EVERx to satisfy demand. Now the constraints are off and I expect we will see substantial EVERx sales growth in the second half of 2019.
We did get our production capacity under wraps in time to realize the first phase of an order for a private labeled CBD infused water. That gave us a nice boost in sales. However, it also came with an added expense. Both the expense of expanding our production capacity and setting up production for a private labeled product took a toll on our margins. However, that added expense is not recurring and we anticipate improved margins in the following two quarters of this year.
In addition to our revenue growth and the outlook for continued revenue growth and improving margins, PURA also took a big step forward recently on the issuance of the Nouveau, Inc. (NOUV) stock dividend intended for distribution to PURA shareholders. PURA spun-off its cannabis cultivation operation last year to NOUV in a deal that includes a planned distribution of NOUV stock to PURA shareholders. The orchestration of such a dividend issuance is not trivial. It takes some time to get it executed. You will notice on the most recent financial report that NOUV has recently issued preferred stock to PURA. We will in turn distribute the NOUV stock soon to PURA shareholders in a dividend distribution.
Source: finance.yahoo.com/ne...llion-130000709.html
PURA Is A First Mover In The CBD Sports Market. Already Ahead Of Aurora Cannabis
Pura today complimented Aurora Cannabis on its strategy to pursue the legal hemp derived CBD market in the United States (US). Aurora Cannabis has just announced plans to pursue the legal hemp derived CBD opportunity in the US focusing first on the sports market where PURA has already made a name for itself. Aurora Cannabis has entered into a clinical research partnership with the UFC (Ultimate Fighting Championship). Aurora Cannabis has voiced its intention on assessing CBD’s potential for treating sports related pain and aiding recovery. PURA has been focused on the sports nutrition market since its introduction of EVERx CBD Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival in 2017. EVERx has sponsored multiple MMA (mixed martial arts events) to include sponsoring UFC fighters. EVERx has worked with UFC Fighter Julianna Pena, UFC Fighter Cee Jay Hamilton and two-time Super Bowl quarterback champion Jim McMahon. PURA is the sole licensee of Kali-Extracts (KALY) patented cannabis extraction process and has access to KALY’s extensive research on various applications of CBD extracts. PURA has gone global with its marketing of EVERx CBD Sports Water participating in the Arnold Sports Festival worldwide. PURA is launching a European EVERx CBD Sports Water marketing campaign this week at the Arnold Sports Festival in Barcelona, Spain. PURA management views Aurora Cannabis’s US Strategy on target and a validation of PURA’s long-term strategy.
PURA Speculative Buy Recommendation and Priced Target Increased to $0.35
Goldman Small Cap Research recently released a new research report recommending PURA as a Speculative BUY with a $0.35 PPS Target.
Highlights From The Report:
The Bottom Line: In recent trading sessions, PURA’s stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks.
Our Take: Why is the stock down? This question is as old as equity trading itself. We do not purport to have all the answers. However, it has been our experience that oftentimes, certain prices serve as a hurdle for stocks and a catalyst for traders, those taking money off the table, and short sellers. PURA has been under steady pressure since reaching a recent high of $0.099 about ten days ago. That figure was reached shortly after our survey report which quickly turned into a doubling in share price. So, we had a quick rise followed by quick fall. Since we believe that the bulk of trading pressure is largely behind it, a combination of fundamental shifts and potential short covering should drive the stock much higher.
Final Survey Results on Their Way and…The data is great for PURA.—plus there is a surprise along with this release late next week.
So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks.
Today, PURA Trades At a Ridiculous 5x Our Preliminary 2020 EBITDA Estimate. Our target is 30x. That is serious upside potential.
Source: www.goldmanresearch....c-pura-spec-buy.html
Market Outlook:
If possible, the European cannabis legalization environment is more chaotic than in the United States.
Forbes reports: “In the European Union, the legal status of cannabis varies by country. Medical cannabis is legal in Germany, Czech Republic, Italy and Malta. The UK is also moving to legalize medical cannabis. The status of edibles in the EU is legally unclear.”
Nevertheless, the Brightfield Group predicts the EU market for CBD to reach $1.7 billion by 2023.
PURA has specialized in navigating the market dynamics associated with the early market adoption of cannabis products where rules and regulations are not clear and ever changing yet market demand has sent a clear message that consumers are ready for and looking for cannabis products. PURA’s business comes from a spin-off of a cannabis extraction business previously owned by North American Cannabis Holdings, Inc (USMJ) which was started in 2013, early on in the cannabis consumer market. PURA management has garnered a wealth of knowledge and experience anticipated to help the company navigate the rapidly growing opportunity in Europe.
In addition to the market experience PURA has gained from its early entry, PURA has also amassed substantial product experience. Not all CBD extracts are created equal and the infusion of CBD into a beverage or edible is not as easy as simply mixing CBD in a mixing bowl. PURA has experienced shelf-life problems, among other issues and in turn, resolved the problems. PURA’s hands on experience and U.S. market presence has made PURA a target of interest of more than one major beverage brand name.
PURA’s EVERx CBD Sports Water and new CBD beverages in the works which will be included in the new distribution agreement, benefit from PURA’s sole license of a U.S. Patented Cannabis Extraction Process for beverage infusion from Kali-Extracts, Inc. (KALY). USMJ originally entered into a contract with NCM Biotech, the company that originally owned the Patented Cannabis Extraction Process. USMJ spun the contract off to PURA and NCM Biotech was subsequently acquired by KALY.
Technical Analysis:
As the research report stated, there appears to have been no rhyme or reason on why PURA's stock was selling off.
All we know is that its recent downtrend has created a perfect opportunity for traders to build a position in a Company that is on target to double its year-over-year revenue.
Its $0.35 Price Target suggests an upside of +400% from today's alert price.
After a deep retrace, RSI trend is now confirmed as support, which suggests that bargain hunters are now scooping up shares, and that a lovely rebound is in the works.
Based on our very own chart analysis, we are anticipating a move of around +30% from here.
PURA is the perfect trade for those looking to avoid the recent doom and gloom surrounding the market.
Start your research, add it to the top of your watchlist, and be ready to trade tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
*Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report have received compensation from a third party of USD $10,000 cash for a 1-day marketing contract for PURA. Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.
Best Regards,
Puration, Inc. (PURA)
Alert Price: $0.0698
Price Target: $0.35 (Goldman Small Cap Research)
Float: 537.87M
Website | Recent News
========================
Members,
U.S. stocks tumbled sharply today, extending Tuesday’s declines after a weak batch of economic data sparked concerns over the pace of global and domestic growth.
With all the doom and gloom surrounding Wall St., it's been extremely difficult to find any bright spots.
One sector that did stand out however was Cannabis.
And one company that stood out particularly was Puration, Inc. (PURA).
PURA closed the day out near session highs, while trading on higher than average volume.
This is normally a strong sign of bullish momentum, and from a technical perspective, this appears to be a no brainer,.
However, there is so much more to this company than just strong technicals.
PURA has witnessed growth of 87%, and is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
PURA Will Soon Be Grabbing The Full Attention Of Wall St.
CBD Beverage Industry Survey Update Coming Next Week Followed By Next New Beverage Announcement
Today the Company announced plans to release additional information from its recent CBD beverage industry survey. Earlier today, PURA announced that Goldman Small Cap Research has issued an “Alert” follow-up to a recent Research Analyst Report issued on PURA. The Research Analyst Report was triggered by an earlier CBD Beverage Industry Survey conducted on behalf of a PURA initiative to launch new CBD infused beer, coffee and tea beverages. The trade alert today indicates the definitive survey results and analysis will be coming next week in a further update to be issued by Goldman.
PURA Announces Trade Alert Featuring "Rare Entry" Opportunity With "Triple" Potential
Today PURA announced a research analyst trade alert highlighting a "rare entry" price opportunity for the shares of PURA and the potential for the share price to triple from current levels. Early last week, PURA reached a PPS of $0.09 more than doubling the PPS from a week earlier. On Wednesday last week, September 25th, 2019, Goldman Small Cap Research issued an analyst research report recommending a speculative buy and $0.35 target PPS. Since that time, the PPS has retraced to close yesterday at $0.06. In reaction to the recent trading activity, Goldman today issued a trade alert.
"In recent trading sessions, PURA's stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks."
Two weeks ago, Goldman published the initial results from a CBD Beverage Industry Survey it had conducted on behalf of a PURA initiative to launch new CBD infused beer, coffee and tea beverages. The trade alert today indicates the definitive survey results and analysis will be coming next week.
The Goldman alert today offers commentary on possible explanations for the recent PURA trading activity:
"So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks."
To see the full trade alert issued today, follow the link below:
www.goldmanresearch....c-pura-spec-buy.html
About Puration Inc.
PURA is already a leading CBD infused beverage company having produced over $1 million in CBD Beverages in the United States last year (2018) and reporting over $1 million in CBD Beverages for just the first six months of 2019. PURA has targeted $4 million in sales for 2019.
For more information on Puration, visit www.purationinc.com
Company Highlights
87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
Announced new distribution agreement for its EVERx CBD Sports Water in Europe anticipated to generate $4 million in annual revenue.
Sales On Track To Reach $4 Million 2019 Revenue Target
Launched a pre-marketing campaign of its new CBD Infused beer, coffee and tea beverages.
Goldman Small Cap Research Confirms PURA Speculative BUY and $0.35 PPS Target (+400%! Upside From Today's Alert Price)
A first mover in the CBD sports market. Already ahead of CBD giant Aurora Cannabis
Recently announced the launch of its EVERx CBD Sports Water marketing campaign in Europe.
EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales in 2018 and over $1 million in sales in the first six months of 2019 and targeting $4 million in sales by 2019 year end. EVERx is now an official sponsor of Jan Tana's Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide.
EVERx CBD Sports Water is available for purchase on line at www.USMJ.com hosted by PURA's partner North American Cannabis Holdings, Inc. (USMJ).
Bullish Catalysts for PURA
First Shipment of EVERx CBD Sports Water Heads to Europe Next Month
$4 Million 2020 Projection for New Distribution Agreement
PURA New TranquiliTeaCBD Beverage Included in Shipments by Year End
Agreement Supports Analyst Rev Projection and Spec Buy w/$0.35 TGT PPS
Analysts Project $8M in Revenue this Year
Last week the Company announced the European Distribution Agreement for their EVERx CBD Sports Water and other future CBD infused beverages coming soon. The distributor is a supplier to a grocery chain with approximately 4 Billion Euro in annual sales. The agreement is anticipated to generate one million dollars in sales per quarter in 2020 supporting a recent analyst projection for PURA sales reaching $8 million next year (see more on the $8 million 2020 projection below). The first shipment will go out to the new European Distributor next month and Q4 2019 sales will contribute to refining the 2020 $4 million forecast. PURA expects to add its new TranquiliTeaCBD beverage introduced yesterday to the European Distribution shipments before the end of 2020.
In reaction to shareholder questions regarding the new distribution agreement recently announced, PURA confirmed that the anticipated $4 million from the new distribution agreement is separate from and on top of the existing $4 million, 2019 revenue target.
Source: finance.yahoo.com/ne...llion-161115964.html
PURA 2019 $4 Million Revenue Target On Track And Shareholders Are One Big Step Closer To Receiving Stock Dividend
PURA Reports 87% Growth To Over $1 Million In Sales For 1st Six Months Of 2019
PURA Posts $122,000 Net Income From Operations
Sales On Track To Reach $4 Million 2019 Revenue Target
NOUV Issues Preferred Stock To PURA For PURA Shareholder Dividend
In August the Company published a management update in conjunction with the recently published 2019 Q2 Financial Report. The company reported over $1 million in revenue for the first six months of 2019. The 2019 revenue for the first six months of 2019 is 87% higher than the revenue reported for the same period in 2018. The company also posted $122,000 in net income from operations for the first six months of 2019.
CEO Brian Shibley Update:
PURA has announced a $4 million revenue target for 2019. The company broke $1 million in sales for the 2018 fiscal year. I believe the Q2 2019 report demonstrates that the company can reach its $4 million revenue target.
I actually believe sales could have been even higher in the first six months of 2019. We had reached production capacity on our EVERx CBD Sports Water and spent considerable time and effort in the first half of the year overcoming our production constraints. Had we not been constrained, I believe we would have realized more sales in the first two quarters. We simply could not make enough EVERx to satisfy demand. Now the constraints are off and I expect we will see substantial EVERx sales growth in the second half of 2019.
We did get our production capacity under wraps in time to realize the first phase of an order for a private labeled CBD infused water. That gave us a nice boost in sales. However, it also came with an added expense. Both the expense of expanding our production capacity and setting up production for a private labeled product took a toll on our margins. However, that added expense is not recurring and we anticipate improved margins in the following two quarters of this year.
In addition to our revenue growth and the outlook for continued revenue growth and improving margins, PURA also took a big step forward recently on the issuance of the Nouveau, Inc. (NOUV) stock dividend intended for distribution to PURA shareholders. PURA spun-off its cannabis cultivation operation last year to NOUV in a deal that includes a planned distribution of NOUV stock to PURA shareholders. The orchestration of such a dividend issuance is not trivial. It takes some time to get it executed. You will notice on the most recent financial report that NOUV has recently issued preferred stock to PURA. We will in turn distribute the NOUV stock soon to PURA shareholders in a dividend distribution.
Source: finance.yahoo.com/ne...llion-130000709.html
PURA Is A First Mover In The CBD Sports Market. Already Ahead Of Aurora Cannabis
Pura today complimented Aurora Cannabis on its strategy to pursue the legal hemp derived CBD market in the United States (US). Aurora Cannabis has just announced plans to pursue the legal hemp derived CBD opportunity in the US focusing first on the sports market where PURA has already made a name for itself. Aurora Cannabis has entered into a clinical research partnership with the UFC (Ultimate Fighting Championship). Aurora Cannabis has voiced its intention on assessing CBD’s potential for treating sports related pain and aiding recovery. PURA has been focused on the sports nutrition market since its introduction of EVERx CBD Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival in 2017. EVERx has sponsored multiple MMA (mixed martial arts events) to include sponsoring UFC fighters. EVERx has worked with UFC Fighter Julianna Pena, UFC Fighter Cee Jay Hamilton and two-time Super Bowl quarterback champion Jim McMahon. PURA is the sole licensee of Kali-Extracts (KALY) patented cannabis extraction process and has access to KALY’s extensive research on various applications of CBD extracts. PURA has gone global with its marketing of EVERx CBD Sports Water participating in the Arnold Sports Festival worldwide. PURA is launching a European EVERx CBD Sports Water marketing campaign this week at the Arnold Sports Festival in Barcelona, Spain. PURA management views Aurora Cannabis’s US Strategy on target and a validation of PURA’s long-term strategy.
PURA Speculative Buy Recommendation and Priced Target Increased to $0.35
Goldman Small Cap Research recently released a new research report recommending PURA as a Speculative BUY with a $0.35 PPS Target.
Highlights From The Report:
The Bottom Line: In recent trading sessions, PURA’s stock has taken it on the chin, and undeservedly so, in our opinion, Savvy investors seeking huge returns from a major bounce-back candidate should strongly consider current prices as an entry point to establish or build on their position. For a number of reasons, we believe PURA will trade three times higher or more in the coming weeks.
Our Take: Why is the stock down? This question is as old as equity trading itself. We do not purport to have all the answers. However, it has been our experience that oftentimes, certain prices serve as a hurdle for stocks and a catalyst for traders, those taking money off the table, and short sellers. PURA has been under steady pressure since reaching a recent high of $0.099 about ten days ago. That figure was reached shortly after our survey report which quickly turned into a doubling in share price. So, we had a quick rise followed by quick fall. Since we believe that the bulk of trading pressure is largely behind it, a combination of fundamental shifts and potential short covering should drive the stock much higher.
Final Survey Results on Their Way and…The data is great for PURA.—plus there is a surprise along with this release late next week.
So, let me get this straight, sales are going to double, new markets are opening, other initiatives are in process and the stock is going down? Buy on rumor sell on news, huh? Fundamentally, PURA is in its best position ever, the valuation is compelling, and the CBD train is picking up steam. These situations rarely do not right themselves and seasonally, we foresee the bulk of big gains over the next 4-8 weeks.
Today, PURA Trades At a Ridiculous 5x Our Preliminary 2020 EBITDA Estimate. Our target is 30x. That is serious upside potential.
Source: www.goldmanresearch....c-pura-spec-buy.html
Market Outlook:
If possible, the European cannabis legalization environment is more chaotic than in the United States.
Forbes reports: “In the European Union, the legal status of cannabis varies by country. Medical cannabis is legal in Germany, Czech Republic, Italy and Malta. The UK is also moving to legalize medical cannabis. The status of edibles in the EU is legally unclear.”
Nevertheless, the Brightfield Group predicts the EU market for CBD to reach $1.7 billion by 2023.
PURA has specialized in navigating the market dynamics associated with the early market adoption of cannabis products where rules and regulations are not clear and ever changing yet market demand has sent a clear message that consumers are ready for and looking for cannabis products. PURA’s business comes from a spin-off of a cannabis extraction business previously owned by North American Cannabis Holdings, Inc (USMJ) which was started in 2013, early on in the cannabis consumer market. PURA management has garnered a wealth of knowledge and experience anticipated to help the company navigate the rapidly growing opportunity in Europe.
In addition to the market experience PURA has gained from its early entry, PURA has also amassed substantial product experience. Not all CBD extracts are created equal and the infusion of CBD into a beverage or edible is not as easy as simply mixing CBD in a mixing bowl. PURA has experienced shelf-life problems, among other issues and in turn, resolved the problems. PURA’s hands on experience and U.S. market presence has made PURA a target of interest of more than one major beverage brand name.
PURA’s EVERx CBD Sports Water and new CBD beverages in the works which will be included in the new distribution agreement, benefit from PURA’s sole license of a U.S. Patented Cannabis Extraction Process for beverage infusion from Kali-Extracts, Inc. (KALY). USMJ originally entered into a contract with NCM Biotech, the company that originally owned the Patented Cannabis Extraction Process. USMJ spun the contract off to PURA and NCM Biotech was subsequently acquired by KALY.
Technical Analysis:
As the research report stated, there appears to have been no rhyme or reason on why PURA's stock was selling off.
All we know is that its recent downtrend has created a perfect opportunity for traders to build a position in a Company that is on target to double its year-over-year revenue.
Its $0.35 Price Target suggests an upside of +400% from today's alert price.
After a deep retrace, RSI trend is now confirmed as support, which suggests that bargain hunters are now scooping up shares, and that a lovely rebound is in the works.
Based on our very own chart analysis, we are anticipating a move of around +30% from here.
PURA is the perfect trade for those looking to avoid the recent doom and gloom surrounding the market.
Start your research, add it to the top of your watchlist, and be ready to trade tomorrow morning at 9:30AM EST
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
*Past performance is not an indicator of future returns. The publishers of this report are not investment advisors and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The publishers of this report have received compensation from a third party of USD $10,000 cash for a 1-day marketing contract for PURA. Never make investment decisions based on anything the publisher of this report says. This message is meant for informational and educational purposes only and does not provide investment advice.
Best Regards,